508 related articles for article (PubMed ID: 21261711)
1. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
3. HCV in patients with end-stage renal disease.
Okoh EJ; Bucci JR; Simon JF; Harrison SA
Am J Gastroenterol; 2008 Aug; 103(8):2123-34. PubMed ID: 18796105
[TBL] [Abstract][Full Text] [Related]
4. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety.
Russo MW; Goldsweig CD; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Jul; 98(7):1610-5. PubMed ID: 12873587
[TBL] [Abstract][Full Text] [Related]
5. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
Kamar N; Ribes D; Izopet J; Rostaing L
Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.
Posthouwer D; Mauser-Bunschoten EP; Fischer K; Makris M
Haemophilia; 2006 Sep; 12(5):473-8. PubMed ID: 16919076
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C infection and the patient with end-stage renal disease.
Fabrizi F; Poordad FF; Martin P
Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis C virus and chronic progressive kidney disease].
Kes P; Slavicek J
Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
[TBL] [Abstract][Full Text] [Related]
11. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
12. Treatment of HCV in patients with renal failure.
Kalia H; Lopez PM; Martin P
Arch Med Res; 2007 Aug; 38(6):628-33. PubMed ID: 17613354
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis.
Rocha CM; Perez RM; Ferreira AP; Carvalho-Filho RJ; Pace FH; Silva IS; Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
Liver Int; 2006 Apr; 26(3):305-10. PubMed ID: 16584392
[TBL] [Abstract][Full Text] [Related]
14. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
15. [Retreatment of patients with chronic hepatitis C].
Ostojić R
Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
[TBL] [Abstract][Full Text] [Related]
16. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
Giannini EG; Basso M; Savarino V; Picciotto A
Aliment Pharmacol Ther; 2010 Feb; 31(4):502-8. PubMed ID: 19925499
[TBL] [Abstract][Full Text] [Related]
17. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
[TBL] [Abstract][Full Text] [Related]
19. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
[TBL] [Abstract][Full Text] [Related]
20. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
Terrault NA; Adey DB
Clin J Am Soc Nephrol; 2007 May; 2(3):563-75. PubMed ID: 17699464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
